Patients
ONCOLOGY, DISEASE
Eligible women (aged 18 years or over) had epithelial ovarian, epithelial fallopian tube cancer or primary peritoneal cancer; they had received up to two previous platinum-based chemotherapy regimens, of which at least one must have contained a taxane and had relapsed between 6 and 12 months after the last dose of the platinum-based chemotherapy; they had Eastern Cooperative Oncology Group (ECOG) performance status ≤2 and adequate organ function, with measurable or evaluable disease confirmed by radiological imaging.